Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

Active hexose correlated compound (AHCC) enhances resistance to infection in a mouse model of surgical wound infection.

Aviles H, O'Donnell P, Sun B, Sonnenfeld G.

Surg Infect (Larchmt). 2006 Dec;7(6):527-35.

PMID:
17233570
2.

Active hexose correlated compound activates immune function to decrease bacterial load in a murine model of intramuscular infection.

Aviles H, O'Donnell P, Orshal J, Fujii H, Sun B, Sonnenfeld G.

Am J Surg. 2008 Apr;195(4):537-45. doi: 10.1016/j.amjsurg.2007.05.045.

PMID:
18304499
3.

Active hexose correlated compound enhances resistance to Klebsiella pneumoniae infection in mice in the hindlimb-unloading model of spaceflight conditions.

Aviles H, Belay T, Fountain K, Vance M, Sun B, Sonnenfeld G.

J Appl Physiol (1985). 2003 Aug;95(2):491-6. Epub 2003 Apr 11.

4.

Active hexose correlated compound enhances the immune function of mice in the hindlimb-unloading model of spaceflight conditions.

Aviles H, Belay T, Vance M, Sun B, Sonnenfeld G.

J Appl Physiol (1985). 2004 Oct;97(4):1437-44. Epub 2004 Jun 11.

5.

Oral administration of active hexose correlated compound enhances host resistance to West Nile encephalitis in mice.

Wang S, Welte T, Fang H, Chang GJ, Born WK, O'Brien RL, Sun B, Fujii H, Kosuna K, Wang T.

J Nutr. 2009 Mar;139(3):598-602. doi: 10.3945/jn.108.100297. Epub 2009 Jan 13.

6.

Supplementation with active hexose correlated compound increases survival following infectious challenge in mice.

Ritz BW.

Nutr Rev. 2008 Sep;66(9):526-31. doi: 10.1111/j.1753-4887.2008.00085.x. Review.

PMID:
18752476
7.

Active Hexose Correlated Compound Activates Immune Function to Decrease Chlamydia trachomatis Shedding in a Murine Stress Model.

Belay T, Fu CL, Woart A.

J Nutr Med Diet Care. 2015;1(1). pii: JNMDC-1-006. Epub 2015 Sep 15.

8.

Low-dose supplementation with active hexose correlated compound improves the immune response to acute influenza infection in C57BL/6 mice.

Nogusa S, Gerbino J, Ritz BW.

Nutr Res. 2009 Feb;29(2):139-43. doi: 10.1016/j.nutres.2009.01.005.

PMID:
19285605
9.

The influence of active hexose correlated compound (AHCC) on cisplatin-evoked chemotherapeutic and side effects in tumor-bearing mice.

Hirose A, Sato E, Fujii H, Sun B, Nishioka H, Aruoma OI.

Toxicol Appl Pharmacol. 2007 Jul 15;222(2):152-8. Epub 2007 Apr 20.

PMID:
17555784
10.

Active hexose correlated compound enhances tumor surveillance through regulating both innate and adaptive immune responses.

Gao Y, Zhang D, Sun B, Fujii H, Kosuna K, Yin Z.

Cancer Immunol Immunother. 2006 Oct;55(10):1258-66. Epub 2005 Dec 16.

PMID:
16362410
11.

Short-term supplementation with active hexose correlated compound improves the antibody response to influenza B vaccine.

Roman BE, Beli E, Duriancik DM, Gardner EM.

Nutr Res. 2013 Jan;33(1):12-7. doi: 10.1016/j.nutres.2012.11.001. Epub 2012 Dec 4.

PMID:
23351405
12.

Genotoxicity and subchronic toxicity evaluation of Active Hexose Correlated Compound (AHCC).

Fujii H, Nishioka N, Simon RR, Kaur R, Lynch B, Roberts A.

Regul Toxicol Pharmacol. 2011 Mar;59(2):237-50. doi: 10.1016/j.yrtph.2010.10.006. Epub 2010 Oct 14.

PMID:
20951179
13.

Improved prognosis of postoperative hepatocellular carcinoma patients when treated with functional foods: a prospective cohort study.

Matsui Y, Uhara J, Satoi S, Kaibori M, Yamada H, Kitade H, Imamura A, Takai S, Kawaguchi Y, Kwon AH, Kamiyama Y.

J Hepatol. 2002 Jul;37(1):78-86.

PMID:
12076865
14.
15.

Trehalose dimycolate enhances resistance to infection in neutropenic animals.

Madonna GS, Ledney GD, Elliott TB, Brook I, Ulrich JT, Myers KR, Patchen ML, Walker RI.

Infect Immun. 1989 Aug;57(8):2495-501.

16.

Informative value of a mouse model of Klebsiella pneumoniae infection used as a host-resistance assay.

Malina J, Hofmann J, Fran─Ľk J.

Folia Microbiol (Praha). 1991;36(2):183-91.

PMID:
1823654
17.

Prognostic improvement of patients with advanced liver cancer after active hexose correlated compound (AHCC) treatment.

Cowawintaweewat S, Manoromana S, Sriplung H, Khuhaprema T, Tongtawe P, Tapchaisri P, Chaicumpa W.

Asian Pac J Allergy Immunol. 2006 Mar;24(1):33-45.

18.
19.

A Phase I study of the safety of the nutritional supplement, active hexose correlated compound, AHCC, in healthy volunteers.

Spierings EL, Fujii H, Sun B, Walshe T.

J Nutr Sci Vitaminol (Tokyo). 2007 Dec;53(6):536-9.

20.

Alleviating effect of active hexose correlated compound (AHCC) for anticancer drug-induced side effects in non-tumor-bearing mice.

Shigama K, Nakaya A, Wakame K, Nishioka H, Fujii H.

J Exp Ther Oncol. 2009;8(1):43-51.

PMID:
19827270

Supplemental Content

Support Center